A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 ...
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
There’s no data from a head-to-head trial directly comparing Eli Lilly and ... study has found that Lilly’s tirzepatide seems to be better at achieving weight loss. Tirzepatide – a dual ...
The singer reflected on being ‘so broken and dark’ a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback